偏头痛患者的脑钠(23Na)磁共振成像——病例对照研究
本研究为病例对照研究,纳入24例女性偏头痛患者(其中12例合并紧张型头痛)与12例健康女性对照,在3.0 T下行脑23Na磁共振成像,测量脑脊液、灰白质、脑干及小脑的钠浓度。结果显示患者脑脊液23Na浓度显著高于健康对照(p < 0.001),且患者疼痛水平与脑脊液总钠浓度呈正相关(r = 0.62)。
要点
- 偏头痛患者脑脊液23Na浓度显著高于健康对照(p < 0.001)。
- 偏头痛组与偏头痛合并紧张型头痛组脑脊液钠浓度均显著高于对照组(p = 0.007和p < 0.001)。
- 患者疼痛水平与脑脊液总钠浓度呈正相关(r = 0.62)。
核心结论
- 偏头痛患者脑脊液23Na浓度显著高于健康对照,提示离子失衡可能参与偏头痛病理生理。
研究设计与样本
- 病例对照研究,纳入24例女性偏头痛患者(平均年龄34 ± 11岁,其中12例合并紧张型头痛)和12例健康女性对照(平均年龄34 ± 11岁),在3.0 T下行脑23Na磁共振成像,包括T1w MP-RAGE序列和3D密度自适应径向梯度回波序列,以外部23Na参考体模计算组织总钠浓度。
关键影像表现/征象
- 脑脊液、灰质、白质、脑干及小脑为预设解剖区域,置圆形感兴趣区测量23Na浓度。
- 患者组脑脊液23Na浓度显著高于健康对照组(p < 0.001)。
- 偏头痛组脑脊液钠浓度显著高于对照组(p = 0.007),偏头痛合并紧张型头痛组亦显著高于对照组(p < 0.001)。
- 患者疼痛水平与脑脊液总钠浓度呈正相关(r = 0.62)。
临床应用与阅片要点
- 脑23Na磁共振成像可能成为无创影像工具,用于在分子水平评估调节钠的药物及其对偏头痛的影响,并可能影响患者管理(作者认为)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Evaluation of MRI-derived cerebral 23Na concentrations in patients with migraine in comparison with healthy controls.
MATERIALS AND METHODS: In this case-control study, 24 female migraine patients (mean age, 34 ± 11 years) were enrolled after evaluation of standardized questionnaires. Half (n = 12) of the cohort suffered from migraine, the other half was impaired by both migraine and tension-type headaches (TTH). The combined patient cohort was matched to 12 healthy female controls (mean age, 34 ± 11 years). All participants underwent a cerebral 23Na-magnetic resonance imaging examination at 3.0 T, which included a T1w MP-RAGE sequence and a 3D density-adapted, radial gradient echo sequence for 23Na imaging. Circular regions of interests were placed in predetermined anatomic regions: cerebrospinal fluid (CSF), gray and white matter, brain stem, and cerebellum. External 23Na reference phantoms were used to calculate the total 23Na tissue concentrations. Pearson's correlation, Kendall Tau, and Wilcoxon rank sum test were used for statistical analysis.
RESULTS: 23Na concentrations of all patients in the CSF were significantly higher than in healthy controls (p < 0.001). The CSF of both the migraine and mixed migraine/TTH group showed significantly increased sodium concentrations compared to the control group (p = 0.007 and p < 0.001). Within the patient cohort, a positive correlation between pain level and TSC in the CSF (r = 0.62) could be observed.
CONCLUSION: MRI-derived cerebral 23Na concentrations in the CSF of migraine patients were found to be statistically significantly higher than in healthy controls.
KEY POINTS: • Cerebral sodium MRI supports the theory of ionic imbalances and may aid in the challenging pathophysiologic understanding of migraine. • Case-control study shows significantly higher sodium concentrations in cerebrospinal fluid of migraineurs. • Cerebral sodium MRI may become a non-invasive imaging tool for drugs to modulate sodium, and hence migraine, on a molecular level, and influence patient management.
引用
- Meyer MM, Schmidt A, Benrath J, et al. Cerebral sodium (23Na) magnetic resonance imaging in patients with migraine - a case-control study. Eur Radiol. 2019. PMID: 31264011. doi:10.1007/s00330-019-06299-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。